
Karyopharm Announces FDA Approval of Xpovio (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
NEWTON, Mass., Dec. 18, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial stage
NEWTON, Mass., Dec. 18, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial stage
People with multiple sclerosis (MS) gradually develop increasing functional impairment. Researchers at Karolinska Institutet have
(HealthDay)—An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment
(HealthDay)—Obesity seems to be associated with increased odds of pediatric multiple sclerosis (MS), according to
The term uncontrollable orgasms might sound like a blessing of good fortune, but trust: It’s
For some women, having multiple orgasms is the sexual Mount Everest of pleasure. However, Stella
A recent study found that nearly 18 percent of patients diagnosed with multiple sclerosis before
Q: My husband was recently diagnosed with kidney stones (lots of them!) and has been